KALA BIO, Inc.
KALA
$9.31
$0.536.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -7.65% | -12.27% | -10.83% | -13.84% | -26.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.71% | -3.80% | 3.27% | 3.46% | -4.97% |
| Operating Income | 1.71% | 3.80% | -3.27% | -3.46% | 4.04% |
| Income Before Tax | 3.85% | 9.86% | 8.74% | 16.06% | -348.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.85% | 9.86% | 8.74% | 16.06% | -348.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.85% | 9.86% | 8.74% | 16.06% | -348.22% |
| EBIT | 1.71% | 3.80% | -3.27% | -3.46% | 4.04% |
| EBITDA | 1.70% | 3.75% | -3.41% | -3.63% | 3.82% |
| EPS Basic | 51.27% | 45.57% | 38.50% | 45.13% | -17,986.92% |
| Normalized Basic EPS | 49.52% | 42.81% | 33.30% | 49.78% | 52.58% |
| EPS Diluted | 51.27% | 45.57% | 38.51% | 45.15% | -18,577.11% |
| Normalized Diluted EPS | 49.52% | 42.81% | 33.30% | 49.78% | 52.45% |
| Average Basic Shares Outstanding | 99.72% | 78.70% | 56.03% | 52.97% | 46.76% |
| Average Diluted Shares Outstanding | 99.72% | 78.70% | 56.03% | 52.97% | 46.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |